Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The development of potent and selective bisarylmaleimide GSK3 inhibitors.
Engler TA, Malhotra S, Burkholder TP, Henry JR, Mendel D, Porter WJ, Furness K, Diefenbacher C, Marquart A, Reel JK, Li Y, Clayton J, Cunningham B, McLean J, O'toole JC, Brozinick J, Hawkins E, Misener E, Briere D, Brier RA, Wagner JR, Campbell RM, Anderson BD, Vaughn R, Bennett DB, Meier TI, Cook JA. Engler TA, et al. Among authors: vaughn r. Bioorg Med Chem Lett. 2005 Feb 15;15(4):899-903. doi: 10.1016/j.bmcl.2004.12.063. Bioorg Med Chem Lett. 2005. PMID: 15686883
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3.
Engler TA, Henry JR, Malhotra S, Cunningham B, Furness K, Brozinick J, Burkholder TP, Clay MP, Clayton J, Diefenbacher C, Hawkins E, Iversen PW, Li Y, Lindstrom TD, Marquart AL, McLean J, Mendel D, Misener E, Briere D, O'Toole JC, Porter WJ, Queener S, Reel JK, Owens RA, Brier RA, Eessalu TE, Wagner JR, Campbell RM, Vaughn R. Engler TA, et al. Among authors: vaughn r. J Med Chem. 2004 Jul 29;47(16):3934-7. doi: 10.1021/jm049768a. J Med Chem. 2004. PMID: 15267232
Discovery of potent, cyclic calcitonin gene-related peptide receptor antagonists.
Yan LZ, Johnson KW, Rothstein E, Flora D, Edwards P, Li B, Li J, Lynch R, Vaughn R, Clemens-Smith A, McCarty D, Chow C, McKnight KL, Lu J, Nisenbaum ES, Mayer JP. Yan LZ, et al. Among authors: vaughn r. J Pept Sci. 2011 May;17(5):383-6. doi: 10.1002/psc.1358. Epub 2011 Mar 15. J Pept Sci. 2011. PMID: 21412957
Erythematous Plaques on the Eyelids.
Bettis VM, Vaughn RY, Guill MA. Bettis VM, et al. Among authors: vaughn ry. Arch Dermatol. 1993 Apr 1;129(4):495-6. doi: 10.1001/archderm.1993.01680250109017. Arch Dermatol. 1993. PMID: 27081774
The treatment of lichen nitidus with astemizole.
Vaughn RY, Smith JG Jr. Vaughn RY, et al. J Am Acad Dermatol. 1990 Oct;23(4 Pt 1):757-8. doi: 10.1016/s0190-9622(08)81081-x. J Am Acad Dermatol. 1990. PMID: 1977775 No abstract available.
Histogenesis of vascular tumors in the Proteus syndrome.
Vaughn RY, Lesher JL Jr, Chandler FW, O'Quinn JL, Hobbs JL, Howell CG, Edgerton MT. Vaughn RY, et al. South Med J. 1994 Feb;87(2):228-32. doi: 10.1097/00007611-199402000-00016. South Med J. 1994. PMID: 8115889
135 results